Filter
99
Filtered Results: 99
Text search:
heterologous
Featured
Recommendations
9
New Publications
14
Language
Document type
Guidelines
39
No document type
32
Studies & Reports
12
Manuals
5
Fact sheets
5
Strategic & Response Plan
4
Situation Updates
1
Infographics
1
Countries / Regions
Brazil
8
India
6
Argentina
5
Africa
3
Latin America and the Carribbean
3
South Africa
3
Nigeria
2
Mozambique
2
Paraguay
2
Bolivia
2
Russia
2
Chile
1
Philippines
1
Global
1
Asia
1
Tanzania
1
Germany
1
East and Southern Africa
1
Uganda
1
Indonesia
1
Ecuador
1
Authors & Publishers
Publication Years
Category
Guidelines
23
COVID-19
22
Rabies
4
Policies
3
Non-communicable Diseases
3
Virology
2
Malaria
2
Paediatrics
1
Clinical Training
1
Hematology
1
Vaccine-preventable Diseases
1
Yellow Fever
1
Policies & Guidelines HIV & TB
1
Drugs & Medical Equipment
1
Studies & Reports
1
NTDs & Others
1
Dengue
1
Parasitology
1
Disease Prevention & Control
1
Toolboxes
Country specific documents
13
Inactivated COVID-19 Vaccines
10
Booster Doses
9
Immunization Guidelines
8
Biontech/Pfizer Comirnaty
7
Vaxzevria (Astra Zeneca)
6
Moderna
4
Access & Strategy
3
Research & Access
3
Fair Allocation & Ethical Aspects
2
Johnson & Johnson
2
Covaxin
2
Clinical Aspects & Diagnostics
2
Studies & Reports
2
Zika
2
Laboratory & Diagnostics
2
Assessment & Studies
1
Vaccines & Immunization
1
Yellow Fever
1
Pediatrics
1
Dengue
1
HIV
1
TB
1
IACAPAP International Association for Child and Adolescent Psychiatry and Allied Professions
1
Children/Adolescents Mental Disorders
1
Vaccination
1
Children
1
Clinical Guidelines
1
COVID-19
1
For Parents & Children
1
For Older People
1
Communication Material
1
Dashboards & Resource Platforms
1
SARS-CoV-2 Variants
1
Vector-based Vacines General
1
Sputnik V
1
Chile
1
Traditional & Herbal Medicines
1
Zoonoses
1
MPOX - Monkeypox
1
Clinical Aspects & Diagnostics
1
Statistics & Facts
1
Studies & Reports
1
Studies & Reports
1
General Information & Methodology
1
Prevention & Strategies
1
Neurological Disorders
1
Food & Nutrition
1
Neurological disorders, Others
1
Vaccins antirabiques: Note de synthèse de l’OMS – avril 2018
Weekly epidemiological record / Relevé épidémiologique hebdomadaire
20 APRIL 2018, 93th YEAR / 20 AVRIL 2018, 93e ANNÉE
Weekly epidemiological record / Relevé épidémiologique hebdomadaire
20 APRIL 2018, 93th YEAR / 20 AVRIL 2018, 93e ANNÉE
Trials (2017) 18:152, DOI 10.1186/s13063-017-1881-z
These WHO interim recommendations on the use of the Pfizer – BioNTech BNT162b2 vaccine against Covid-19 were developed on the basis of advice issued by the Strategic Advisory Group of Experts on Immunization (SAGE) and the evidence summary included in the background document referenced below.
fir...
nterim guidance, first issued 25 January 2021, updated 15 June 2021, updated 19 November 2021, updated 23 February 2022, updated 18 August 2022
orientations provisoires, première publication : 8 janvier 2021, mise à jour : 15 juin 2021, mise à jour : 19 novembre 2021, mise à jour : 21 janvier 2022
orientations provisoires, première publication: 10 février 2021, mise à jour : 21 avril 2021, dernière mise à jour : 30 juillet 2021
временное руководство. Первый выпуск: 10 февраля 2021 г. Обновлено: 21 апреля 2021 г. Последнее обновление 30 июля 2021г.
Esta orientação provisória foi desenvolvida com base na recomendação emitida pelo Grupo Consultivo Estratégico de Especialistas (SAGE) em imunização, em sua reunião extraordinária de 5 de janeiro de 2021, e atualizada durante sua reunião extraordinária de 27 de maio de 2021 (2), sendo no...
Interim guidance, 26 October 2021
This interim guidance has been developed on the basis of the advice issued by the Strategic Advisory Group of Experts (SAGE) on Immunization at its meeting on 5 October 2021.
SAGE said moderately and severely immunocompromised persons should be offered an addition...
Временное руководство, Первый выпуск 8 января 2021 г., Обновлено 15 июня 2021 г., Обновлено 19 ноября 2021 г.
Updated Treatment Guidelines
Interim recommendations for the use of ChAdOx1-S [recombinant] COVID-19 vaccine (AstraZeneca COVID-19 AZD1222 Vaxzevria™, SII COVISHIELD™ vaccine) - Last updated 30 July 2021
an approach to optimize the global impact of COVID-19 vaccines, based on public health goals, global and national equity, and vaccine access and coverage scenarios, first issued 20 October 2020, updated: 13 November 2020, updated: 16 July 2021, latest update: 21 January 2022
Available in English, F...
O SAGE aplica os princípios da medicina baseada em evidências e estabeleceu um processo metodológico completo para emitir ou atualizar recomendações. Especificamente para vacinas contra a COVID-19, uma descrição detalhada dos processos metodológicos pode ser encontrada no esquema de evidênc...
Mass vaccination campaigns to prevent coronavirus disease 2019 (Covid-19) are occurring in many countries; estimates of vaccine effectiveness are urgently needed
to support decision making. A countrywide mass vaccination campaign with the
use of an inactivated severe acute respiratory syndrome c...
The Committee discussed the implications for preparedness for smallpox-like events reflected by the ongoing COVID-19 pandemic. The Committee noted how quickly diagnostics and vaccines could be developed and deployed when resources and political will were abundant. This rapidity was also due to the f...
